You are here:Home-Chemical Inhibitors & Agonists-NF-κB Pathway-NF-κB inducing Kinase (NIK)-CW15337
CW15337

Chemical Structure : CW15337

CAS No.: 1202764-38-2

CW15337 (CW 15337)

Catalog No.: PC-20834Not For Human Use, Lab Use Only.

CW15337 is a potent and highly selective inhibitor of NF-κB-inducing kinase (NIK) with Ki of 25 nM in biochemical assays, does not inhibit IKKα or IKKβ kinase activity.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

CW15337 is a potent and highly selective inhibitor of NF-κB-inducing kinase (NIK) with Ki of 25 nM in biochemical assays, does not inhibit IKKα or IKKβ kinase activity.
CW15337 downregulates Bcl-XL and increases sensitivity to venetoclax against esistant CLL cells.
The combination of CW15337 and ABT-199 (venetoclax) reversed the drug resistance observed when treating tumor cells with ABT-199 alone.
CLL cells derived from patients showed increased nuclear p52 and high sensitivity to CW15337.

Physicochemical Properties

M.Wt 294.36
Formula C17H18N4O
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

CC(O)(C)C#CC1=CC2=C(C=C1)CCN2C3=NC(N)=NC=C3

References

1. Marco Haselager, et al. Cell Death Differ. 2021 May;28(5):1658-1668.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: